Author

Lauren Horlbogen

Observed names: Horlbogen, Lauren, Lauren M. Horlbogen

Institution: Pfizer (United States)

Observed institution: Pfizer (United States)

OpenAlex ID: A5036820399

Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers

2020 · Takeshi Miyake, Emi Kimoto, et al. · Clinical Pharmacology & Therapeutics · 48

A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) Biomarker

2020 · Lina Luo, Ragu Ramanathan, et al. · Analytical Chemistry · 33

Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in Nigeria

2021 · Ogochukwu Amaeze, Heather Eng, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 22

Development and Implementation of Urinary Transporter Biomarkers to Facilitate Assessment of Drug–Drug Interaction

2022 · Lina Luo, Manoli Vourvahis, et al. · Bioanalysis · 2

Works count: 5

Citation count: 105

H-index: 3

I10-index: 3